Language Selection

YOU ARE USING THE CNPHI QA SYSTEM (LIBERTY)
Français

Molecular Detection and Genotyping

<<Return to Laboratory
Accredited by the Standards Council of Canada to Laboratory no. 594 - CAN-P-4E (ISO/IEC 17025)

Requisition Forms

Reference Details

Description:

Molecular detection of the mumps virus by real-time RT-PCR and genotyping of positive specimens.

Test Category:
Molecular Detection and Genotyping
Pathogen:
Mumps virus
Illnesses and Diseases:
  • Mumps
Specimen:

Urine (collected within 2 weeks post onset), parotid gland/buccal swabs or throat swabs, saliva (collected within 5 days post onset). Note: specimens collected later will still be accepted however the assay sensitivity will not be optimal. CSF may be submitted for meningitis/encephalitis cases. Viral isolates may also be sent.

Collection Method:

Collect 50 mL (minimum 10 mL) of urine in sterile container. For swabs, collect specimens using sterile swabs approved for virus isolation and place in 2 -3 mL of viral transport medium (VTM) for a minimum of 1 hour. For saliva, mix with equal part VTM. For viral isolate, collect infected cells and media and submit 1.0 mL at minimum. For CSF, submit at minimum 0.5 mL in a sterile collection vial.

Specimen Processing, Storage and Shipping:

Process urine by centrifuging at 2500 x g for 15 minutes at 4EC. Resuspend the sediment in 2.0 mL VTM. For swab specimens, remove the swab. For all specimens, store at 4°C and ship on wet ice for arrival at the NML within 2 days from collection. Otherwise, freeze at -70°C and ship frozen on dry ice. Viral Isolates should be shipped frozen (-70°C) on dry ice.

 

Transportation of Dangerous Goods:

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.

Patient Criteria:

High fever, fatigue and unilteral or bilateral parotitis. Suspect mumps meningitis/encephalitis cases.

Accompanying Documentation:

Completed Measles, Mumps, and Rubella requisition form. Include date of symptom onset, date of last mumps vaccination (if recent) and travel history.

 

Comments:

Labs that perform their own mumps RT-PCR testing should submit positive samples for genotype surveillance. It is important to provide a complete patient history (including travel) for accurate genotype surveillance.

Methods and Interpretation of Results:

Extracted RNA from samples is tested by real-time RT-PCR for the mumps Fusion gene (2). A positive RT-PCR result is laboratory confirmation of mumps infection. The WHO standardised region, the small hydrophobic (SH) gene, of positive samples is amplified by conventional RT-PCR and sequenced to determine the genotype of the mumps virus (1).

 

Turnaround Time:

Molecular detection: 7 calendar days. Genotyping: 21 calendar days. Stat testing is available upon request.

Contact:
Phone #: (204) 789-7055
Fax: (204) 789-5009
References:
  1. World Health Organization. Mumps virus nomenclature update: 2012. Weekly Epidemiological Record 2012; 87: 217-224.
  2. Uchida K, M Shinohara, S Shimada et al. Rapid and sensitive detection of mumps virus RNA directly from clinical samples by real-time PCR. J Med Virology 2005;75:470–4.
  3. Public Health Agency of Canada. Laboratory guidelines for the diagnosis of mumps. CCDR. 2010; 36S1: 37-41.
  4. Tipples G, J Hiebert. Detection of measles, mumps and rubella viruses. Methods Mol Biol. 2011; 665: 183-193.
Fact Sheets:
Guidelines: